Morphometric Signature Differences in Nuclei of Gleason Pattern 4 Areas in Gleason 7 Prostate Cancer With Differing Primary Grades on Needle Biopsy

被引:13
|
作者
Venkataraman, Girish [1 ]
Rycyna, Kevin [3 ]
Rabanser, Alexander [6 ]
Heinze, Georg [6 ]
Baesens, Bart M. M. [5 ]
Ananthanarayanan, Vijayalakshmi [4 ]
Paner, Gladell P. [1 ]
Barkan, Gueliz A. [1 ]
Flanigan, Robert C. [2 ]
Wojcik, Eva M. [1 ]
机构
[1] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Urol, Maywood, IL 60153 USA
[3] Loyola Univ, Med Ctr, Stritch Sch Med, Maywood, IL 60153 USA
[4] Univ Illinois, Dept Pathol, Chicago, IL USA
[5] Univ Southampton, Sch Management, Southampton, Hants, England
[6] Med Univ Vienna, Core Unit Med Stat & Informat, Vienna, Austria
来源
JOURNAL OF UROLOGY | 2009年 / 181卷 / 01期
关键词
prostate; adenocarcinoma; decision trees; biopsy; cell nucleus; IMAGE-ANALYSIS; SCORE; RADIOTHERAPY; CARCINOMA; SURVIVAL;
D O I
10.1016/j.juro.2008.09.013
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Since clinically significant upgrading of the biopsy Gleason score has an adverse clinical impact, ancillary tools besides the visual determination of primary Gleason pattern are essential to aid in better risk stratification. Materials and Methods: A total of 61 prostate biopsies were selected in patients with a diagnosis of Gleason score 7 prostatic adenocarcinoma, including 41 with primary Gleason pattern 3 and 20 with primary Gleason pattern 4. Slides from these tissues were stained using Feulgen stain, a nuclear DNA stain. Areas of Gleason pattern in all cases were analyzed for 40 nuclear morphometric descriptors of size, shape and chromatin using a CAS-200 system (BD (TM)). The primary outcome analyzed was the ability of morphometric features to identify visually determined primary Gleason pattern 4 on the biopsy. Data were analyzed using logistic regression as well as a C4.5 decision tree with and without preselection. Results: Decision tree analysis yielded the best model. Automatic feature selection identified minimum nuclear diameter as the most discriminative feature in a 3-parameter model with 85% classification accuracy. Using a preselected 3-parameter model including minimum diameter, angularity and sum optical density the decision tree yielded a slightly lesser accuracy of around 79%. Bootstrap validation of logistic regression results revealed that there was no unique model that could significantly explain the variance in primary Gleason pattern status, although minimum nuclear diameter was the most frequently selected parameter. Conclusions: In this small cohort of patients with Gleason score 7 disease we report that Gleason pattern 4 nuclei from those with primary Gleason pattern 4 are generally larger with coarser chromatin compared with the Gleason pattern 4 in patients with primary Gleason pattern 3. These findings may aid in better risk stratification of the Gleason score 7 group by supplementing visual estimation of the percent of primary Gleason pattern 3 and 4 in the biopsy.
引用
收藏
页码:88 / 93
页数:6
相关论文
共 50 条
  • [1] Morphometric Signature Differences in Nuclei of Gleason Pattern 4 Areas in Gleason 7 Prostate Cancer With Differing Primary Grades on Needle Biopsy COMMENTS
    Veltri, Robert
    JOURNAL OF UROLOGY, 2009, 181 (01): : 94 - 94
  • [2] Distinctive morphometric signatures exist within nuclei of gleason pattern 4 areas in gleason 7 prostate cancer with differing primary grades on needle biopsy
    Venkataraman, G.
    Rycyna, K.
    Ananthanarayanan, V.
    Hutchens, K. A.
    Paner, G. P.
    Flanigan, R. C.
    Wojcik, E. M.
    MODERN PATHOLOGY, 2008, 21 : 360A - 360A
  • [3] Distinctive morphometric signatures exist within nuclei of gleason pattern 4 areas in gleason 7 prostate cancer with differing primary grades on needle biopsy
    Venkataraman, G.
    Rycyna, K.
    Ananthanarayanan, V.
    Hutchens, K. A.
    Paner, G. P.
    Flanigan, R. C.
    Wojcik, E. M.
    LABORATORY INVESTIGATION, 2008, 88 : 360A - 360A
  • [4] Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological outcomes in Gleason 7 tumors
    Grober, ED
    Nam, RK
    Sweet, JM
    Evans, AJ
    Jewett, MAS
    Trachtenberg, J
    Robinette, M
    Tsihlias, J
    JOURNAL OF UROLOGY, 2002, 167 (04): : 228 - 228
  • [5] Relationship between primary Gleason pattern on needle biopsy and clinicopathological outcomes among men with Gleason 7 adenocarcinoma of the prostate
    Gonzalgo, ML
    Bastian, PJ
    Mangold, LA
    Epstein, JI
    Walsh, PC
    Partin, AW
    JOURNAL OF UROLOGY, 2005, 173 (04): : 271 - 271
  • [7] Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate
    Gonzalgo, ML
    Bastian, PJ
    Mangold, LA
    Trock, BJ
    Epstein, JI
    Walsh, PC
    Partin, AW
    UROLOGY, 2006, 67 (01) : 115 - 119
  • [8] Quantifying Gleason Pattern 4 Prostate Cancer in Prostate Needle Biopsy: An Interobserver Reproducibility Study
    Li, Jianhong
    Li, Jianbo
    Amin, Ali
    Bhalla, Ritu
    Das, Kasturi
    Deng, Fang-Ming
    Lee, Peng
    Matoso, Andres
    Melamed, Jonathan
    Mendrinos, Savvas
    Tian, Wei
    Yaskiv, Oksana
    Shah, Rajal
    Zhou, Ming
    MODERN PATHOLOGY, 2016, 29 : 246A - 246A
  • [9] Quantifying Gleason Pattern 4 Prostate Cancer in Prostate Needle Biopsy: An Interobserver Reproducibility Study
    Li, Jianhong
    Li, Jianbo
    Amin, Ali
    Bhalla, Ritu
    Das, Kasturi
    Deng, Fang-Ming
    Lee, Peng
    Matoso, Andres
    Melamed, Jonathan
    Mendrinos, Savvas
    Tian, Wei
    Yaskiv, Oksana
    Shah, Rajal
    Zhou, Ming
    LABORATORY INVESTIGATION, 2016, 96 : 246A - 246A
  • [10] A comparison of biochemical relapse free survival (bRFS) between primary Gleason 3 and primary Gleason 4 for biopsy Gleason 7 prostate cancer
    Burdick, M. J.
    Reddy, C. A.
    Ciezki, J. P.
    Ulchaker, J.
    Angermeier, K.
    Altman, A.
    Chehade, N.
    Mahadevan, A.
    Kupelian, P. A.
    Klein, E. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S360 - S360